CD47 blockade may also enhance tumor radiosensitivity via improved CD8 T cell immunosurveillance in syngeneic mouse models[18], STING-based tumor visibility[73], and selective upregulation of protective pathways against oxidative stress and upregulation of DNA repair in normal tissues[74]. This evidence concerns the gene STING1 and neoplasm.